Patent · US Active

MART-1 T cell receptors

US8552150B2 · kind B2 · utility

1Cited by
21References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 17, 2012
Grant dateOct 8, 2013
Priority date
Expiry dateFeb 17, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

T-cell receptors that recognize MART-1 antigen are provided. The TCRs can be used, for example, to treat patients suffering from melanoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.